147 related articles for article (PubMed ID: 23250100)
1. Analysis of fetal and maternal results from fetal genetic invasive procedures: an exploratory study at a University Hospital.
Kohatsu M; Carvalho MH; Vieira Francisco RP; Amorim Filho AG; Zugaib M
Rev Assoc Med Bras (1992); 2012; 58(6):703-8. PubMed ID: 23250100
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of cytogenetic findings on chorionic villus sampling (CVS)--diagnostic consequences of CVS mosaicism and non-mosaic discrepancy in centres contributing to EUCROMIC 1986-1992.
Hahnemann JM; Vejerslev LO
Prenat Diagn; 1997 Sep; 17(9):801-20. PubMed ID: 9316125
[TBL] [Abstract][Full Text] [Related]
3. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
4. A retrospective exploratory study of fetal genetic invasive procedures at a University Hospital.
Andrew C; Koshy T; Gopal S; Paul SFD
J Obstet Gynaecol; 2018 Oct; 38(7):906-910. PubMed ID: 29553859
[TBL] [Abstract][Full Text] [Related]
5. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
Audibert F; Gagnon A; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
[TBL] [Abstract][Full Text] [Related]
6. Clinical Practice Guidelines for Prenatal Aneuploidy Screening and Diagnostic Testing from Korean Society of Maternal-Fetal Medicine: (2) Invasive Diagnostic Testing for Fetal Chromosomal Abnormalities.
Lee JY; Kwon JY; Na S; Choe SA; Seol HJ; Kim M; Kim MA; Park CW; Kim K; Ryu HM; Hwang HS; Shim JY
J Korean Med Sci; 2021 Jan; 36(4):e26. PubMed ID: 33496085
[TBL] [Abstract][Full Text] [Related]
7. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
[TBL] [Abstract][Full Text] [Related]
8. Summary of 2185 prenatal invasive procedures in a single center: A retrospective analysis.
Özcan HÇ; Uğur MG; Sucu S; Mustafa A; Bayramoğlu Tepe N; Balat Ö
Turk J Obstet Gynecol; 2017 Jun; 14(2):114-120. PubMed ID: 28913147
[TBL] [Abstract][Full Text] [Related]
9. [Karyotype analysis of amniotic fluid cells and comparison of chromosomal abnormality rate during second trimester].
Zhang YP; Wu JP; Li XT; Lei CX; Xu JZ; Yin M
Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):644-8. PubMed ID: 22176986
[TBL] [Abstract][Full Text] [Related]
10. Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study.
Tabor A; Vestergaard CH; Lidegaard Ø
Ultrasound Obstet Gynecol; 2009 Jul; 34(1):19-24. PubMed ID: 19504504
[TBL] [Abstract][Full Text] [Related]
11. Indications for Fetal Invasive Procedures at the End of an Era.
Krapp M; Thomsen Y; Ludwig A; Enzensberger C; Kreiselmaier P
Ultraschall Med; 2017 Jan; 38(1):78-82. PubMed ID: 25830343
[No Abstract] [Full Text] [Related]
12. Chorionic villus sampling for abnormal screening compared to historical indications: prevalence of abnormal karyotypes.
Marshall NE; Fraley G; Feist C; Burns MJ; Pereira L
J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1463-6. PubMed ID: 22098166
[TBL] [Abstract][Full Text] [Related]
13. Early amniocentesis and fetal nuchal translucency in women requesting karyotyping for advanced maternal age.
Salvesen DR; Goble O
Prenat Diagn; 1995 Oct; 15(10):971-4. PubMed ID: 8587866
[TBL] [Abstract][Full Text] [Related]
14. Nuchal translucency and the acceptance of invasive prenatal chromosomal diagnosis in women aged 35 and older.
Zoppi MA; Ibba RM; Putzolu M; Floris M; Monni G
Obstet Gynecol; 2001 Jun; 97(6):916-20. PubMed ID: 11384696
[TBL] [Abstract][Full Text] [Related]
15. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities.
Rhoads GG; Jackson LG; Schlesselman SE; de la Cruz FF; Desnick RJ; Golbus MS; Ledbetter DH; Lubs HA; Mahoney MJ; Pergament E
N Engl J Med; 1989 Mar; 320(10):609-17. PubMed ID: 2645520
[TBL] [Abstract][Full Text] [Related]
16. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
Spencer K; Nicolaides KH
BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
[TBL] [Abstract][Full Text] [Related]
17. Serum parameters and nuchal translucency in first trimester screening for fetal chromosomal abnormalities.
Zimmermann R; Hucha A; Savoldelli G; Binkert F; Achermann J; Grudzinskas JG
Br J Obstet Gynaecol; 1996 Oct; 103(10):1009-14. PubMed ID: 8863700
[TBL] [Abstract][Full Text] [Related]
18. Increased nuchal translucency as a marker for fetal chromosomal defects.
Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P
N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency.
Pandya PP; Kondylios A; Hilbert L; Snijders RJ; Nicolaides KH
Ultrasound Obstet Gynecol; 1995 Jan; 5(1):15-9. PubMed ID: 7850583
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing.
Lau TK; Chen F; Pan X; Pooh RK; Jiang F; Li Y; Jiang H; Li X; Chen S; Zhang X
J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1370-4. PubMed ID: 22070770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
